INS and Alzheimer disease: Subsequently, Kaplan–Meier curve analysis disclosed that patients receiving pioglitazone and insulin had a significantly higher cumulative risk of developing AD than those using pioglitazone alone or insulin alone (all p < 0.001, Fig. 3).